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Summary
 
The I
 
k
 
B kinase (IKK) complex is composed of three subunits, IKK
 
a
 
, IKK
 
b
 
, and IKK
 
g
 
(NEMO). While IKK
 
a
 
 and IKK
 
b
 
 are highly similar catalytic subunits, both capable of I
 
k
 
B
phosphorylation in vitro, IKK
 
g
 
 is a regulatory subunit. Previous biochemical and genetic anal-
yses have indicated that despite their similar structures and in vitro kinase activities, IKK
 
a
 
 and
IKK
 
b
 
 have distinct functions. Surprisingly, disruption of the 
 
Ikk
 
a
 
 locus did not abolish activa-
tion of IKK by proinflammatory stimuli and resulted in only a small decrease in nuclear factor
(NF)-
 
k
 
B activation. Now we describe the pathophysiological consequence of disruption of the
 
Ikk
 
b
 
 locus. IKK
 
b
 
-deficient mice die at mid-gestation from uncontrolled liver apoptosis, a phe-
notype that is remarkably similar to that of mice deficient in both the RelA (p65) and NF-
 
k
 
B1
(p50/p105) subunits of NF-
 
k
 
B. Accordingly, IKK
 
b
 
-deficient cells are defective in activation of
IKK and NF-
 
k
 
B in response to either tumor necrosis factor 
 
a
 
 or interleukin 1. Thus IKK
 
b
 
,
but not IKK
 
a
 
, plays the major role in IKK activation and induction of NF-
 
k
 
B activity. In the
absence of IKK
 
b
 
, IKK
 
a
 
 is unresponsive to IKK activators.
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T
 
he nuclear factor (NF)-
 
k
 
B
 
1
 
 transcription factor plays a
key role in activation of inflammatory and innate im-
mune responses (1, 2). In nonstimulated cells, NF-
 
k
 
B
dimers are kept as cytoplasmic latent complexes through
binding of specific inhibitors, the I
 
k
 
Bs, which mask their
nuclear localization signal (NLS). Upon exposure to proin-
flammatory stimuli, such as bacterial LPS, TNF-
 
a
 
, or IL-1,
the I
 
k
 
Bs are rapidly phosphorylated at two conserved NH
 
2
 
-
terminal serines, a posttranslational modification that is rap-
idly followed by their polyubiquitination and proteasomal
degradation (3–6). This results in unmasking of the NLS of
NF-
 
k
 
B dimers followed by their translocation to the nu-
cleus, binding to specific DNA sites (
 
k
 
B sites), and target
gene activation. NF-
 
k
 
B target genes include many of the
cytokine and chemokine genes, as well as genes coding for
adhesion molecules, cell surface receptors, and enzymes
that produce secondary inflammatory mediators (7, 8).
The protein kinase that phosphorylates I
 
k
 
Bs in response
to proinflammatory stimuli has been identified biochemically
and molecularly (9–11). Named IKK, this protein kinase is a
complex composed of at least three subunits: IKK
 
a
 
, IKK
 
b
 
and IKK
 
g
 
 (for a review, see reference 12). IKK
 
a
 
 and IKK
 
b
 
are highly similar protein kinases that act as the catalytic sub-
units of the complex (9, 11, 13, 14). In vitro, both IKK
 
a
 
 and
IKK
 
b
 
 form homo- and heterodimers that can phosphorylate
I
 
k
 
B proteins at their NH
 
2
 
-terminal regulatory serines (15).
In mammalian cells, IKK
 
a
 
 and IKK
 
b
 
 form a stable hetero-
dimer that is tightly associated with the IKK
 
g
 
 (NEMO) sub-
unit (16, 17). As cell lines that fail to express IKK
 
g
 
 (NEMO)
exhibit a major defect in I
 
k
 
B degradation and NF-
 
k
 
B activa-
tion in response to proinflammatory stimuli and double-
stranded RNA, this regulatory subunit plays an essential
function (at least in the examined cell lines) in IKK and
NF-
 
k
 
B activation (17). The physiological function of the
two catalytic subunits has been less clear. Initially, overex-
pression of catalytically inactive forms of IKK
 
a
 
 and IKK
 
b
 
that blocked IKK and NF-
 
k
 
B activation suggested that both
subunits play similar and possibly redundant roles in I
 
k
 
B
phosphorylation and NF-
 
k
 
B activation (13, 14). This hy-
pothesis was fostered by finding that in vitro IKK
 
a
 
 and
 
1
 
Abbreviations used in this paper:
 
 EF, embryonic fibroblast; EMSA, electro-
phoretic mobility shift assay; ES, embryonic stem; H&E, hematoxylin and
eosin; IKK, I
 
k
 
B kinase; NF, nuclear factor; NIK, NF-
 
k
 
B inducing ki-
nase; TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP
nick-end labeling. 
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IKK
 
b
 
 can directly phosphorylate I
 
k
 
B
 
a
 
 and I
 
k
 
B
 
b
 
 at the
serines that trigger their degradation in vivo (15). However,
it was also suggested that IKK
 
a
 
 rather than IKK
 
b
 
 is responsi-
ble for activation of the entire complex in response to certain
stimuli, such as the NF-
 
k
 
B inducing kinase, NIK (18). Re-
cently, we found that in addition to an IKK
 
g
 
 subunit with
an intact COOH terminus (16), IKK activation requires the
phosphorylation of IKK
 
b
 
 at two serines within its activation
loop (19). Replacement of these serines, whose phosphory-
lation is stimulated by proinflammatory stimuli or NIK, with
alanines abolishes IKK activation. Interestingly, although the
entire activation loop is identical in sequence between IKK
 
a
 
and IKK
 
b
 
, replacement of the same two serines in IKK
 
a
 
with alanines has no effect on IKK activation (19). These re-
sults were further substantiated by gene targeting (knockout)
experiments. Cells and tissues from mice that no longer ex-
press IKK
 
a
 
 (
 
Ikk
 
a
 
2
 
/
 
2
 
 mice) exhibit normal IKK activation in
response to TNF, IL-1, or LPS (20). Although NF-
 
k
 
B is
fully inducible, for an unknown reason, IKK
 
a
 
-deficient
fibroblasts exhibit approximately twofold reduction in both
basal and induced NF-
 
k
 
B binding activity (20). Thus, IKK
 
a
 
may somehow stimulate NF-
 
k
 
B DNA binding despite not
being required for I
 
k
 
B phosphorylation and degradation in
most cell types. The gene targeting experiments reveal that,
although not involved in activation of IKK by proinflamma-
tory stimuli, IKK
 
a
 
 plays an instrumental role in morphogen-
esis (20). The most important function of IKK
 
a
 
 appears to
be in the control of keratinocyte differentiation and forma-
tion of the epidermis (20). It is not yet clear whether these
morphogenetic functions of IKK
 
a
 
 are exerted through lo-
calized NF-
 
k
 
B activation in response to developmental cues.
To determine the physiological function(s) of IKKb, we
have used gene targeting to create Ikkb knockout mice.
We now show that the loss of IKKb results in embryonic
lethality at mid-gestation due to extensive apoptosis of the
developing liver. This phenotype is similar to that of mice
deficient in the RelA (p65) subunit of NF-kB (21). It was
recently shown that the lethality of RelA2/2 mice is com-
pletely suppressed by the loss of TNF-a (22). As NF-kB is
required for protection of cells from TNF-a–induced ap-
optosis (23–25), the apoptotic phenotype of Ikkb2/2 mice
strongly suggests that the absence of IKKb results in a se-
vere defect in NF-kB activation. Indeed, neither IKK nor
NF-kB can be activated by TNF-a or IL-1 in IKKb-defi-
cient cells. Furthermore, we show that in the absence of
IKKb, the IKKa subunit is not responsive to NIK even
though it can still associate with the IKKg subunit.
Materials and Methods
Generation of IKKb-deficient Mice. Using a 0.2-kb BstEII-Bsu36I
restriction fragment from the 59 end of human IKKb cDNA as a
probe, three murine IKKb genomic fragments were isolated from
a 129/SvJ mouse genomic library (Stratagene, Inc.). One of the
clones contained at least the first three coding exons and was used
to construct the targeting vector IKKbKO. A 1.4-kb SacI restric-
tion fragment harboring part of the second exon was used as the
short homology arm, and the long arm was a 5.5-kb EcoRV-
XhoI restriction fragment containing part of the third intron. The
two arms were inserted into the XmnI and SmaI sites, respec-
tively, of pGNA, which contains the G418 resistance gene (Neor)
and LacZ (26). As a negative selection marker, a diphtheria toxin
gene cassette (DT) was inserted into the KpnI site of pGNA. Af-
ter cutting with PmeI, 20 mg of the linearized targeting vector
was electroporated into 107 mouse embryonic stem (ES) cells
(line GS from Genome Systems). After selection with G418 at
0.4 mg/ml, G418-resistant colonies were picked and screened by
PCR. The genotype of the PCR-positive clones was confirmed
by Southern blotting analysis. Homologous recombinants were
karyotyped and analyzed for mycoplasma. Two homologous re-
combinant ES clones were injected into C57BL/6 blastocysts.
Resulting male chimeras were crossed with C57BL/6 females,
and germline transmission was scored by coat color. Heterozy-
gous mice were identified by PCR and Southern analysis of
Figure 1. Generation of IKKb-deficient mice. (A) The mouse Ikkb locus and the targeting vector. Map of
the Ikkb genomic fragment used for gene targeting is shown. The exons are indicated by solid black boxes, the
introns are indicated by bold lines, and the selection markers, lengths of restriction fragments, restriction en-
zyme sites, the probes used for Southern analysis, and the location of primers used in PCR screening are also
shown. RI, EcoRI; P, PstI; S, SacI; RV, EcoRV; Xh, XhoI. (B) Southern blot analysis of mouse genomic
DNA. Mouse genomic DNA was digested with EcoRI and probed with probe A (1.2-kb HindIII-PstI frag-
ment of Ikkb). After homologous recombination, the 9.7-kb EcoRI fragment of wild-type Ikkb is replaced by a
7.2-kb EcoRI fragment, as indicated in panel A. (C) Western blot analysis of mouse proteins using antibody
H470 specific for IKKb. Location of the IKKb band is indicated. The lower band is nonspecific (ns). The
same blot was also probed with antibodies to IKKa, IKKg, p65(RelA), and p50(NF-kB1). The genotypes are
as indicated.1841 Li et al.
mouse tail DNA. Embryos from intercrosses of heterozygous
(Ikkb1/2) mice, as well as mouse embryonic fibroblasts (EFs),
were genotyped by PCR and Southern analysis using DNA iso-
lated from a piece of each embryo or a cell pellet, respectively.
PCR and Southern Blotting Analysis. PCR was performed in
the presence of 10% DMSO with Taq DNA polymerase using a
Perkin-Elmer 9600 thermocycler programmed for denaturation
at 958C for 5 min, amplification for 35 cycles (948C for 30 s,
558C for 30 s, 658C for 2 min), and elongation at 728C for 10
min. Primers used were: P1 (59-AGTCCAACTGGCAGCGA-
ATA-39) located outside of the homology arm and P2 (59-CAA-
CATTAAATGTGAGCGAG-39) located within the LacZ gene.
Southern blotting analysis was performed according to a standard
protocol (27) except that hybridization was performed in phos-
phate-SDS buffer (28).
Kinase Assay, Immunoprecipitation, Immunoblotting, and Electro-
phoretic Mobility Shift Assays. Ikkb2/2, Ikkb1/2, and Ikkb1/1 ES
and EF cells were treated with TNF-a or IL-1 at 20 ng/ml. Ki-
nase assays and immunoprecipitations were performed as described
(9). Immunoblotting was performed as described (14, 16). Elec-
trophoretic mobility shift assays (EMSAs) using the consensus kB
and NF-1 sequences were performed as described (16, 29).
Histology, In Situ TUNEL Assay, and Transmission Electron Micros-
copy. Mouse embryos or embryo livers were fixed in 10% buf-
fered formalin and embedded in paraffin. After routine processing,
the sections (5-mm thick) were stained with hematoxylin and eosin
(H&E) for histological analysis. In situ TUNEL (terminal deoxy-
nucleotidyl transferase–mediated dUTP nick-end labeling) assay
was done using the in situ cell death detection kit according to the
manufacturer’s instructions (Boehringer Mannheim). For electron
microscopy, embryonic day 13 (E13) embryos were removed and
the livers were dissected out and fixed for 1 h in 2% formaldehyde
and 2% glutaraldehyde in 0.15 M sodium cacodylate buffer (pH
7.4) at 48C. The remainder of the embryos were placed in PBS for
subsequent PCR and Southern analysis. After washing in cacody-
late buffer, the livers were postfixed in 1% osmium tetroxide in ca-
codylate buffer for an additional 1 h. After postfixation, the samples
were rinsed in double distilled water, dehydrated in a graded etha-
nol series, and infiltrated and polymerized in Durcupan ACM resin
(Electron Microscopy Sciences). Sections 80-nm thick were
stained with Sato lead and examined at 80 keV with either a JEOL
100CX or 2000EX transmission electron microscope.
Results
Generation of Ikkb Knockout Mice. To create a strain of
IKKb-deficient mice, we used gene targeting technology
(30). Mouse genomic Ikkb DNA was cloned from a 129
strain library and, after mapping and sequencing, was used
Figure 2. Appearance of an Ikkb2/2 E13.5 embryo and a normal litter-
mate. Wild-type (Ikkb1/1, WT) and mutant (Ikkb2/2, M) embryos were
isolated at E13.5 and photographed. The genotypes of the embryos were
later determined by PCR and Southern blot analysis.
Figure 3. Analysis of wild-
type (WT) and mutant (M) liv-
ers. E13.5 embryos were fixed
and sectioned. Paraffin-embedded
transverse sections at the area of
the liver were subjected to H&E
(top; original magnification: 4003)
or TUNEL (bottom; original
magnification: 6003) staining. The
stained sections were photo-
graphed.1842 IKKb Is Essential for NF-kB Activation
to construct the targeting vector (Fig. 1 A). To eliminate
IKKb kinase activity, part of the second and the entire
third coding exon that specifies an essential part of the ki-
nase domain were replaced with a DNA fragment encod-
ing b-galactosidase (LacZ) and neomycin resistance (Neor).
Because the Neor gene contains transcription termination
and polyadenylation signals, the COOH-terminal three
quarters of IKKb including its protein interaction motifs
are unlikely to be expressed from the targeted allele.
After selection and screening by Southern blotting, six
ES cell clones with homologous integration of the targeting
vector into the Ikkb locus were isolated, and two of them
were used to generate chimeric mice. Chimeric mice de-
rived from these clones transmitted the targeted Ikkb allele
to their progeny (Fig. 1 B). Although Ikkb1/2 male and fe-
male mice appeared normal and were fertile, upon inter-
crossing they did not give rise to live Ikkb2/2 progeny.
Analysis of protein extracts of Ikkb1/1, Ikkb1/2, and
Ikkb2/2 cells revealed that, as expected, no IKKb protein
was expressed from the targeted allele (Fig. 1 C). In addition,
Ikkb1/2 cells expressed approximately half the dose of IKKb
present in wild-type cells. No compensatory increases in
IKKa, IKKg, p65(RelA), or p50(NF-kB1) expression were
observed.
Phenotype of Ikkb2/2 Mice. Given the expected impor-
tance of IKKb for NF-kB activation and the embryonic le-
thality of RelA2/2 mice (21), we suspected that the loss of
IKKb would result in a similar phenotype. Therefore, we
analyzed embryos from timed pregnancies of Ikkb1/2 in-
tercrosses. Although Ikkb2/2 embryos isolated at E11.5 were
alive and had perfectly normal appearance (data not shown),
Ikkb2/2 embryos isolated at E13.5 were no longer alive
and were rather anemic in appearance (Fig. 2). Even exter-
nal examination suggested that the liver of E13.5 Ikkb2/2
embryos had degenerated. Notably, however, the limbs
and head of Ikkb2/2 embryos were normally developed,
unlike those of Ikka2/2 E13.5 embryos (20). Histochemi-
cal examination of transverse sections of normal and mu-
tant E13.5 mouse embryos stained with H&E revealed
massive cell death in livers of Ikkb2/2 embryos (Fig. 3 A).
Essentially, no viable hepatocytes could be detected, and
the numbers of dead cells with highly condensed and frag-
mented nuclei were markedly increased. However, hemato-
poietic precursors retained their normal appearance in Ikkb2/2
livers. TUNEL staining revealed that the observed cell
death is most likely due to apoptosis, whose rate was in-
creased manyfold (Fig. 3 B). Examination of E13 Ikkb2/2
embryos revealed close to normal external appearance (data
not shown), but electronmicroscopic examination of ultra-
thin sections from their livers revealed massive numbers of
dead hepatocytes with highly condensed nuclei characteris-
tic of apoptotic cell death (Fig. 4). The livers of Ikkb1/1 or
Ikkb1/2 littermates had perfectly normal appearance.
Defective NF-kB Activation in Ikkb2/2 Cells. We used two
different approaches to determine the consequences of the
loss of IKKb expression on IKK and NF-kB activation.
First, we prepared Ikkb2/2 ES cell lines by subjecting
Ikkb1/2 ES cells to selection at higher G418 concentration.
One Ikkb2/2 cell line was identified. As shown in Fig. 5 A,
stimulation of these cells with either TNF-a or IL-1 did
not result in IKK activation, whereas a normal activation
response was observed in Ikkb1/2 cells. Note, however, that
Ikkb1/2 cells had z50% of the IKK activity of wild-type
(Ikkb1/1) ES cells, consistent with the reduced amount of
IKKb protein (data not shown). In addition to the defect
in IKK activation, hardly any induction of NF-kB DNA
binding activity was observed in Ikkb2/2 cells after stimula-
tion with either IL-1 or TNF-a (Fig. 5 B). Even the basal
level of NF-kB DNA binding activity was considerably re-
duced in Ikkb2/2 cells, despite no detectable changes in
p65(RelA) or p50(NF-kB1) abundance (data not shown).
The second approach to evaluate the function of IKKb was
to prepare cultures of EFs from E11.5 mouse embryos of all
three genotypes. As shown in Fig. 6, essentially no induc-
Figure 4. Electron microscopic analysis of livers from E13 Ikkb1/1,
Ikkb1/2, and Ikkb2/2 embryos. Both E13 Ikkb1/1 (A) and Ikkb1/2 (B)
livers exhibited normal morphology. The Ikkb2/2 liver (C) exhibited
varying degrees of apoptosis characterized by collapsed and condensed
nuclei and general cellular degeneration. Bars 5 5 mm.1843 Li et al.
tion of IKK or NF-kB activity could be detected in Ikkb2/2
EF cells treated with either IL-1 or TNF-a. Interestingly,
Ikkb1/2 EF cells exhibited an z50% reduction in IKK activ-
ity (consistent with the reduction in IKKb expression) but a
much larger decrease in NF-kB DNA binding activity.
IKKa Cannot Be Activated by NIK in the Absence of
IKKb. The results described above indicate that IKKa,
which is expressed in normal levels in Ikkb2/2 cells, cannot
be activated by either TNF-a or IL-1. To further examine
this point, we cotransfected an HA epitope–tagged IKKa
expression vector into Ikkb2/2 ES cells in the absence or
presence of an NIK expression vector. NIK is the most potent
IKK activator identified to date (31) and was suggested to be a
direct IKKa kinase (18). Recently, however, we obtained
results that suggested that NIK-induced IKKa phosphoryla-
tion is not direct and is likely to be dependent on IKKb (19).
Consistent with this hypothesis, we found no increase in IKK
activity towards IkBa(1-54) substrate upon coexpression of
HA-IKKa with NIK in Ikkb2/2 cells (Fig. 7 A). Yet, when
an IKKb expression vector was included in these transfections,
NIK elicited a clear increase in IKK activity. As shown previ-
ously, NIK coexpression efficiently stimulates IKKa-associ-
ated IKK activity in IKKb-expressing cells (19).
One reason for the inability of IKKa to respond to
proinflammatory stimuli or NIK in the absence of IKKb
could be its inability to directly associate with IKKg, the
regulatory subunit of the IKK complex. Previous experi-
ments indicate that IKKg is essential for recruitment of up-
stream activators to IKK (16). In addition, using recombi-
nant proteins, it was found that IKKb directly interacts
with IKKg much more efficiently than does IKKa (16,
17). Having available IKKb-deficient cells, we reexamined
the ability of IKKa to interact with IKKg. In contrast to
the results obtained with recombinant proteins, very effi-
cient coprecipitation of IKKa by anti-IKKg antibodies was
observed using lysates of Ikkb2/2 cells as a starting material
(Fig. 7 B). Therefore, the refractoriness of IKKa to IKK
activators in IKKb-deficient cells is not due to its inability
to associate with IKKg.
Discussion
The enzymatic activity of the IKK complex, composed
of two catalytic subunits, IKKa and IKKb, and one regula-
tory subunit, IKKg, is rapidly stimulated by proinflamma-
Figure 5. Defective IKK and
NF-kB activation in IKKb-
deficient ES cells. (A) IKK ac-
tivity. Lysates of TNF-a– or
IL-1–treated  Ikkb1/2 and Ikkb2/2
cells were prepared at the indi-
cated time points (in min) after
stimulation and immunoprecipi-
tated with antibody M280 to
IKKa. IKK activity (KA) was
measured by an immunecom-
plex kinase assay using GST-
IkBa(1-54) as a substrate. The ki-
nase assay products were separated
by SDS-PAGE, transferred to ni-
trocellulose membrane, and auto-
radiographed. The membrane was
reprobed with antibody M280
(IB: IKKa) for loading control. (B)
NF-kB binding activity. Nuclear
extracts of Ikkb1/2 and  Ikkb2/2
cells stimulated with IL-1 or
TNF-a for the indicated times
(in min) were incubated with
32P-labeled  kB oligonucleotide
probe and subjected to EMSA.
Binding to an NF-1 probe was
used to control the quality and
amount of nuclear protein extracts.
Figure 6. Defective IKK and NF-kB activation in IKKb-deficient EF
cells. Second passage EFs from E11.5 Ikkb1/1, Ikkb1/2, and Ikkb2/2 em-
bryos were stimulated with TNF-a or IL-1. At the indicated times,
whole cell extracts were prepared and used to measure (A) IKK activity
(KA), and (B) NF-kB DNA binding activity. IB, immunoblotting.1844 IKKb Is Essential for NF-kB Activation
tory cytokines and LPS (for a review, see reference 12).
Activated IKK phosphorylates the different IkBs at the two
NH2-terminal serines that trigger their polyubiquitination
and proteasome-mediated degradation. Once the IkBs are
degraded, the freed NF-kB dimers migrate to the nucleus
and activate target gene transcription. Based on their similar
primary structures (11, 13, 14) and substrate specificities
(15), IKKa and IKKb were expected to play redundant
and interchangeable roles in proinflammatory signaling to
NF-kB. Therefore, it was rather surprising that only IKKb
was found to be involved in IKK activation. Alanine substi-
tutions of the two serines in the activation loop of IKKb,
whose phosphorylation is stimulated by either TNF-a
treatment or NIK overexpression, prevented IKK activa-
tion. Yet, the same mutations introduced into the activa-
tion loop of the IKKa subunit had no effect on the re-
sponse of IKK to TNF-a or NIK (19). These results were
confirmed by the analysis of IKKa-deficient cells and tis-
sues which revealed no defect in IKK activation and IkBa
degradation in response to TNF-a, IL-1, or LPS (20). How-
ever, it remained possible that the function of IKKa in IkB
phosphorylation in response to proinflammatory stimuli can
be fully replaced by IKKb. The results described here indi-
cate that IKKb and IKKa have different physiological func-
tions and that IKKa cannot substitute for IKKb.
To determine the physiological function of IKKb, we
generated Ikkb2/2 knockout mice and cell lines. The loss
of IKKb results in embryonic death at mid-gestation due to
massive hepatocyte apoptosis. This phenotype is remark-
ably similar to that of RelA knockout mice (21), with one
exception: while Ikkb2/2 embryos die around E13, RelA2/2
embryos die around E15. The earlier death of Ikkb2/2 em-
bryos is likely to be due to a more extensive reduction in
NF-kB activity, as embryos that are deficient in both the
p65 (RelA) and the p50 (NF-kB1) subunits of NF-kB die
at E12.5, the same time as IKKb-deficient embryos, from
massive hepatocyte apoptosis (32). Thus, IKKb and RelA
are genetically proven to be components of the same path-
way. Accordingly, cells that lack IKKb are completely de-
fective in IKK and NF-kB activation in response to either
TNF-a or IL-1. Therefore, the IKKb subunit is absolutely
essential for mounting a response to proinflammatory stim-
uli. This function is not replaced by IKKa, whose expres-
sion is not diminished in the absence of IKKb. In addition,
as indicated by the normal morphology of the head and
limbs of E13.5 Ikkb2/2 embryos, IKKa can carry out its
developmental function (20) in the complete absence of
IKKb. Interestingly, a 50% reduction in IKKb expression,
as in Ikkb1/2 cells, results in a similar decrease in IKK ac-
tivity but a much more severe defect in NF-kB activation.
These results underscore the importance of the IKKb sub-
unit and indicate that the NF-kB activation response does
not follow a simple linear relationship to the magnitude of
IKK activation. It also appears from these results that a low
level of NF-kB activity may be sufficient for protecting the
liver from TNF-a–induced apoptosis.
One possible cause for the inability of IKKa to substitute
for IKKb was its relatively lower affinity to IKKg, the regu-
latory subunit that is absolutely required for IKK activation
(17). Using recombinant proteins, it was observed that IKKa
does not form a stable complex with IKKg in vitro, whereas
IKKb readily associates with IKKg (16, 17). However,
immunoprecipitation experiments indicate that a similar
amount of IKKa is precipitated by IKKg antibodies from
Ikkb2/2 cells as from Ikkb1/1 cells. Despite its ability to
associate with IKKg in the absence of IKKb, IKKa is refrac-
tory to upstream activators involved in proinflammatory sig-
naling, including the most potent IKK activator identified so
far, NIK, in IKKb-deficient cells. These results underscore
the differences in regulation of IKKa and IKKb activities.
In summary, together with the previous analysis of IKKa-
deficient mice, the analysis of IKKb-deficient mice, described
here, indicates that the two catalytic subunits of the IKK
complex, although similar in structure, have very different
functions. Although IKKb is responsible both for activation
of the entire complex in response to proinflammatory stimuli,
through phosphorylation at its activation loop, and for activa-
tion of NF-kB, through IkB phosphorylation, IKKa is as-
signed the control of epidermal and skeletal morphogenesis.
Although the stimuli that activate IKKb and the substrates
that mediate its biological activity are known, the stimuli and
the relevant substrates for IKKa remain to be identified.
We thank G. Hageman for the gift of mouse TNF-a, D.M. Rothwarf for advice and technical assistance,
and B. Thompson for assistance with manuscript preparation. 
Figure 7. IKKa is refractory to activation
in Ikkb2/2 cells despite its association with
IKKg. (A) Ikkb2/2 ES cells were transiently
transfected by electroporation with an
HA-IKKa expression vector alone or to-
gether with XpressNIK or HA-IKKb and
XpressNIK expression vectors. 24 h after
transfection, HA-IKK proteins were immu-
noprecipitated (IP) with anti-HA antibody
and their associated IKK activity (KA) was
determined using GST-IkBa(1-54) as a substrate. Protein expression levels were determined by immunoblotting (IB) with anti-HA. (B) Lysates of
Ikkb1/1, Ikkb1/2, and Ikkb2/2 cells were immunoprecipitated (IP) with either anti-IKKa or anti-IKKg antibodies as indicated. The immunecomplexes
were dissolved in SDS loading buffer and separated by SDS-PAGE. After transfer to an Immobilon membrane, the proteins were analyzed by immuno-
blotting (IB) with anti-IKKa antibody. A lysate of 3T3 cells was used as a control (Cont).1845 Li et al.
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